Plus, news about Boundless Bio, Pelage, Actuate Therapeutics and Mersana Therapeutics:
Kyverna Therapeutics touts early safety of CAR-T therapy: The biotech said the first 36 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.